Searched over 200M research papers
10 papers analyzed
These studies suggest metformin doses ranging from 1700 to 3000 mg/day can aid in weight loss for overweight and obese individuals, with effectiveness varying by age, body weight, and insulin resistance.
20 papers analyzed
Metformin, a widely used medication for type 2 diabetes, has also been explored for its potential in promoting weight loss in both diabetic and non-diabetic individuals. This article synthesizes findings from multiple studies to provide insights into the optimal dosages and efficacy of metformin for weight loss.
Several studies have demonstrated that higher doses of metformin can lead to more substantial weight loss in adults. For instance, a systematic review and network meta-analysis found that doses of 3000 mg/day and 1000 mg/day for 6 months were particularly effective in reducing body mass index (BMI) and weight in adults. Another study comparing doses of 1500 mg/day and 2550 mg/day in obese women with polycystic ovary syndrome (PCOS) showed that the higher dose resulted in greater weight loss, particularly in the obese subgroup.
Moderate doses of metformin, such as 2000 mg/day, have also been shown to be effective. In the GRADE study, optimizing metformin to 2000 mg/day resulted in significant improvements in glycemia and modest weight loss. Additionally, a study on non-diabetic individuals with obesity reported an average weight loss of 5.8 kg over six months with a dosage of up to 2500 mg/day.
In adolescents, a dosage of 1000 mg/day for three months was found to be most suitable for weight loss, as higher doses did not show additional benefits. For younger children aged 6-12 years, a randomized controlled trial demonstrated that 1000 mg twice daily for six months led to significant reductions in BMI and body weight.
When compared to other interventions, metformin has shown clear advantages. For example, in a trial comparing metformin to polyethylene glycol loxenatide (PEG-Loxe), metformin resulted in a weight loss of 2.96 kg over 16 weeks, although PEG-Loxe was more effective overall. Another study highlighted that metformin combined with lifestyle interventions led to greater weight loss than lifestyle interventions alone.
The weight loss effects of metformin are partly attributed to its ability to decrease food intake and improve satiety. A study on women with non-insulin-dependent diabetes mellitus (NIDDM) found that metformin reduced calorie intake in a dose-dependent manner, with the 1700 mg dose having the most pronounced effect.
Metformin is an effective medication for weight loss in both diabetic and non-diabetic individuals. Higher doses, such as 2000-3000 mg/day, are generally more effective for adults, while lower doses around 1000 mg/day are suitable for adolescents and children. The medication's ability to reduce food intake and improve satiety contributes to its weight loss effects. Further research is needed to optimize dosing strategies and understand long-term outcomes.
Most relevant research papers on this topic